News AstraZeneca CEO Soriot said to be looking at US listing AstraZeneca chief executive Pascal Soriot is reportedly considering moving the company's stock exchange listing from the UK to the US.
News Barriers are limiting UK childhood vaccination, say doctors Vaccination rates for children are declining in the UK, but it's not just because of vaccine hesitancy.
News New medicine access times to be slashed under NHS plan Reports suggest a new framework for medicine reviews and a push to reduce NHS reliance on overseas-trained staff will feature in the 10-year plan.
News Generic drugmaker Hikma pledges $1bn in US investment With tariffs looming, Indian drugmaker Hikma has said it will spend $1bn to expand its manufacturing and R&D operations in the US by 2030.
News FDA loosens restrictions on first-gen CAR-T therapies There is enough experience with the first wave of autologous CAR-T therapies to allow strict rules ensuring their safe use to be relaxed, says FDA.
News After FDA says no, Bayer bags EU nod for twice-yearly Eylea Bayer has been given a leg up in the competitive market for VEGF therapies used to treat eye diseases with a new EU approval for Eylea 8mg.
News Hengrui to file obesity shot in China after phase 3 win An obesity therapy developed Hengrui Pharma and Kailera is being prepared for its first regulatory submission, in China.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
